Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/24297
Başlık: | The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases |
Yazarlar: | Uludağ Üniversitesi/Tıp Fakültesi/Psikiyatri Anabilim Dalı. Eker, Salih Saygın Sarandol, Aslı Akkaya, Cengiz Sivrioğlu, Enver Yusuf Kırlı, Selçuk Q-9477-2019 14019347700 14020405100 14061855100 14062563200 14019745700 |
Anahtar kelimeler: | Antipsychotic QTc prolongation Ziprasidone Torsade-de-pointes Schizoaffective disorder Antipsychotic-drugs Acute exacerbation Double-blind 160 mg/day Schizophrenia Safety Haloperidol Management Neurosciences & neurology Pharmacology & pharmacy Psychiatry |
Yayın Tarihi: | Kas-2009 |
Yayıncı: | Sage Publications |
Atıf: | Eker, S. S. vd. (2009). "The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases". Journal of Psychopharmacology, 23(8), 993-996. |
Özet: | QTc interval prolongation may appear as a consequence of both typical and atypical antipsychotic treatments. Ziprasidone, which is effective in treating schizophrenia, is associated with QTc prolongation. Although the prolongation of QTc with ziprasidone treatment is often pronounced, there is a scarce number of cases reported about the relationship between ziprasidone and QTc prolongation. Of the three cases presented in this case series, two cases showed values exceeding 0.50 s with ziprasidone treatment. |
URI: | https://doi.org/10.1177/0269881108093843 https://journals.sagepub.com/doi/10.1177/0269881108093843 http://hdl.handle.net/11452/24297 |
ISSN: | 0269-8811 |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.